Min Guo

Artiklar

Article: ONCOGENE. 2021;40(32):5066-5080
SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma
Guo M; Goudarzi KM; Abedi S; Pieber M; Sjoberg E; Behnan J; Zhang X-M; Harris RA; Bartek J; Lindstrom MS; Nister M; Hagerstrand D
Article: CANCER BIOLOGY & MEDICINE. 2021;18(1):139-154
VEGFR2 inhibition hampers breast cancer cell proliferation via enhanced mitochondrial biogenesis
Ni H; Guo M; Zhang X; Jiang L; Tan S; Yuan J; Cui HL; Min Y; Zhang J; Schlisio S; Ma C; Liao W; Nister M; Chen C; Li S; Li N
Article: JOURNAL OF CLINICAL INVESTIGATION. 2020;130(10):5508-5522
Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cells
Yang Y; Neo SY; Chen Z; Cui W; Chen Y; Guo M; Wang Y; Xu H; Kurzay A; Alici E; Holmgren L; Haglund F; Wang K; Lundqvist A
Article: NEURO-ONCOLOGY ADVANCES. 2020;2(1):vdaa061
Identification of functionally distinct and interacting cancer cell subpopulations from glioblastoma with intratumoral genetic heterogeneity
Guo M; van Vliet M; Zhao J; de Stahl TD; Lindstrom MS; Cheng H; Heller S; Nister M; Hagerstrand D
Article: CANCER RESEARCH. 2018;78(20):5901-5916
Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype
Goudarzi KM; Espinoza JA; Guo M; Bartek J; Nister M; Lindstrom MS; Hagerstrand D

Medicine Doktorsexamen, Institutionen för onkologi-patologi, Karolinska Institutet, 2020